JOHNSON CITY, N.Y. — Pharmacy automation manufacturer Innovation will supply pharmacy automation technology to the U.S. Navy, under a new deal between the two worth up to $49 million.
Under a five-year indefinite delivery-indefinite quantity contract, Innovation will supply Navy-operated high-volume sites and outpatient pharmacies around the world. Innovation is known for its PharmASSIST line of products, and the Navy said the company was the only one to fully meet the technical requirements of its published generic functional systems requirement, or GFSR. The contract calls for central acquisition and management that will allow Navy outpatient pharmacies to implement a standardized pharmacy automation system throughout the life of the contract; Navy hospitals previously acquired pharmacy automation systems individually.
"Innovation is pleased that the U.S. Navy has awarded us this significant contract to upgrade their pharmacies' prescription fulfillment processes and quality control," Innovation CEO Mary Reno said. "We look forward to this opportunity to assist Navy pharmacies in achieving their goal of standardized workflow and dispensing platforms. Most importantly, our various technologies will help Navy pharmacies reach the specific quality objectives that they require to ensure the utmost in patient safety for our service men and women."
Innovation said the the main objectives of the Navy initiative are to replace current "end-of-life" pharmacy automation equipment and provide a more standardized process flow for many of the naval outpatient pharmacies; improve the quality of dispensing by reducing the opportunities for errors; increase the volume capability while reducing the wait time for patients; and reduce operating costs related to improved inventory management, efficient staff utilization and increased security.